123 Main Street, New York, NY 10001
The Co-Dx Logix Smart MTB test kit is the first test built using our Co-Primers® technology to receive a CE marking for use as an in vitro diagnostic. It is designed to detect the presence or absence of DNA of Mycobacteria Tuberculosis complex members.
The test uses real-time PCR to amplify the IS6110 and MPB64 regions of the pathogen genome. The amplified product is then detected by fluorescent dyes (FAM, CF560, and CF610).
Includes the complete mix for convenience and an Internal Positive Control (IPC) – Human RNaseP gene marker
Synthetic control intended to amplify all targets included in the kit to ensure integrity of the entire run
Open system and compatible with most qPCR equipment
*Packaging may very depending on region.
The Co-Dx Logix Smart MTB test kit is intended for molecular biology applications. It was designed and validated for use in respiratory tract fluid specimen for detection of presence or absence of Mycobacteria tuberculosis complex, M. bovis, M. africanum, M. canetti, M. microti, and M. pinnipedii through amplification of the bacterial DNA markers IS6110 and MPB64.
The Co-Dx Logix Smart MTB test kit detects the bacteria within 40 cycles from respiratory tract fluid samples. Non-tuberculosis Mycobacteria are commonly present in the lungs and in the environment, and some may cause a tuberculosis-like disease. Mycobacteria can infect or spread to other parts of the body.
The marker IS6110 has been used for decades to detect MTB-complex members, although more recent studies showed that the IS6110 marker was not present in some isolates, and that MPB64 was found as an additional conserved marker to increase the sensitivity of tests designed for detection of the MTB-complex.
* Results based on 556 analytical samples extracted using QIAmp DNA Mini Kits, and run on the Magnetic Induction Cycler (MIC).
Contact us for more information about the Co-Dx Logix Smart MTB test kit.
Every test from Co-Dx is designed to be easy to use.
In July 2018, the Co-Dx Logix Smart MTB test kit received CE mark approval, the principle regulatory clearance allowing the test to be sold as an in vitro diagnostic (IVD) for the diagnosis of tuberculosis in European Union states and other markets that accept a CE-IVD mark as valid regulatory approval.
This product is released for use as an in vitro diagnostic device, for export only and is not for sale in the United States.
Co-Diagnostics, Inc.
2401 S. Foothill Dr. Suite D
Salt Lake City, UT 84109 USA
1 (801) 438-1036
info@co-dx.com
© 2024 Co-Diagnostics, Inc. All Rights Reserved.
Co-Dx, Co-Primers, Logix Smart, Co-Dx Box, PCR Home, PCR Pro, and Vector Smart, and unless otherwise specified, all other product and service names appearing in this Internet site are trademarks owned by Co-Diagnostics, Inc., its subsidiaries or affiliates. No use of any Co-Diagnostic trademark, trade name, or trade dress in this site may be made without the prior written authorization of Co-Diagnostics, except to identify the product or services of the company.
TaqMan is a trademark of Roche Molecular Systems.